Activation of Human T Cell Lymphotropic Virus Type I-Infected T Cells Is Independent of B7 Costimulation

Journal of Immunology

Volumn 157, Issue 7, 1996, Pages 2932-2938

  Scholz, Christian ^a   Freeman, Gordon J ^a   Greenfield, Edward A ^a   Hafler, David A ^a   Höllsberg, Per ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CD86 PROTEIN, HUMAN; GAMMA INTERFERON; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN; INTERLEUKIN 4; INTERLEUKIN 5; JAK3 PROTEIN, HUMAN; JANUS KINASE 3; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MYELIN BASIC PROTEIN; PROTEIN TYROSINE KINASE;

ANIMAL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CELL CLONE; CHO CELL; COMPARATIVE STUDY; CRICETULUS; ENZYME ACTIVATION; GENETIC TRANSFECTION; GENETICS; HAMSTER; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SECRETION; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; AUTOIMMUNITY; BASE SEQUENCE; CHO CELLS; CLONE CELLS; CRICETINAE; CRICETULUS; ENZYME ACTIVATION; HLA-DR ANTIGENS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-5; JANUS KINASE 3; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TRANSFECTION;

EID: 0030265686     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Allison, J. 1994. CD28-B7 interactions in T-cell activation. Curr. Opin. Immunol 6:414.
2. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
3. Thompson, C. 1995. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell 81:979.
4. Freeman, G., J. Gribben, V. Boussiotis, J. Ng, V. Restivo, Jr., L. Lombard, G. Gray, and L. Nadler. 1993. Cloning of B7-2: a counter-receptor that costimulates human T cell proliferation. Science 262:909.
5. Gimmi, C., G. Freeman, J. Gribben, K. Sugita, A. Freedman, C. Morimoto, and L. Nadler. 1991. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88:6575.
6. Jenkins, M. K., P. S. Taylor, S. D. Norton, and K. B. Urdahl. 1991. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147:2461.
7. Schwartz, R. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065.
8. Boussiotis, V., G. Freeman, G. Gray, J. Gribben, and L. Nadler. 1993. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specifk tolerance. J. Exp. Med. 178:1753.
9. Green, J. M., P. J. Noel, A. I. Sperling, T. L. Walunas, G. S. Gray, J. A. Bluestone, and C. B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501.
10. Guerder, S., J. Meyerhoff, and R. Flavell. 1994. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity 1:155.
11. Harlan, D., H. Hengartner, M. Huang, Y. Kang, R. Abe, R. Moreadith, H. Pircher, G. Gray, P. Ohashi, G. Freeman, L. Nadler, C. June, and P. Aichele. 1994. Transgenic mice expressing both B7 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T lymphocyte unresponsiveness. Proc. Natl. Acad. Sci. USA 91:3137.
12. Oldstone, M. 1987, Molecular mimicry and autoimmune disease. Cell 50:819.
13. Conrad, B., E. Weidmann, G. Trucco, W. Rudert, R. Behboo, C. Ricordi, H. Rodriquez-Rilo, D. Finegold, and M. Trucco. 1994. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 371:351.
14. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415.
15. Höllsberg, P., and D. A. Hafler. 1993. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N. Engl. J. Med. 328:1173.
16. Richardson, J. H., A. J. Edwards, J. K. Cruickshank, P. Rudge, and A. G. Dalgleish. 1990. In vivo cellular tropism of human T-cell leukemia virus type I. J. Virol. 64:5682.
17. Wucherpfennig, K. W., A. Sette, S. Southwood, C. Oseroff, M. Matsui, J. L. Strominger, and D. A. Hafler. 1994. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J. Exp. Med. 179:279.
18. Höllsberg, P., K. W. Wucherpfennig, L. J. Ausubel, V. Calvo, B. E. Bierer, and D. A. Hafler. 1992. Characterization of HTLV-1 in vivo infected T cell clones: IL-2 independent growth of nontransformed T cells. J. Immunol. 148:3256.
19. Höllsberg, P., L. J. Ausubel, and D. A. Hafler. 1994. Human T cell lymphotropic virus type I-induced T cell activation: resistance to TGF-β1-induced suppression. J. Immunol. 153:566.
20. Freeman, G., V. Boussiotis, A. Anumanthan, G. Bernstein, X.-Y. Ke, P. Rennert, G. Gray, J. Gribben, and L. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523.
21. te Riele, H., E. R. Maandag, A. Clarke, M. Hooper, and A. Berns. 1990. Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells. Nature 348:649.
22. Valle, A., P. Garrone, H. Yssel, J. Y. Bonnefoy, A. S. Freedman, G. Freeman, L. M. Nadler, and J. Banchereau. 1990. Immunology 69:531.
23. Chlichlia, K., G. Moldenhauer, P. T. Daniel, M. Busslinger, L. Gazzolo, V. Schirrmacher, and K. Khazaie. 1995. Immediate effects of reversible HTLV-1 tax function: T cell activation and apoptosis. Oncogene 10:269.
24. June, C., J. Bluestone, L. Nadler, and C. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
25. Lindsten, T., C. June, J. Ledbetter, G. Stella, and C. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T-cell activation pathway. Science 244:339.
26. Umlauf, S., B. Beverly, O. Lantz, and R. Schwartz. 1995. Regulation of IL-2 gene expression by CD28 costimulation in mouse T-cell clones. Both nuclear and cytoplasmic RNA are regulated with complex kinetics. Mol. Cell. Biol. 15: 3197.
27. Xu, X., S.-H. Kang, O. Heidenreich, M. Okerholm, J. J. O'Shea, and M. I. Nerenberg. 1995. Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type I (HTLV-1) Tax protein or virus-transformed cells. J. Clin. Invest. 96:1548.
28. Migone, T.-S., J.-X. Lin, A. Cereseto, J. C. Mulloy, J. J. O'Shea, G. Franchini, and W. J. Leonard. 1995. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1. Science 269:79.
29. Johnston, J. A., M. Kawamura, R. A. Kirken, Y.-Q. Chen, T. B. Blake, K. Shibuya, J. R. Ortaldo, D. W. McVicar, and J. J. O'Shea. 1994. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370:151.
30. Witthuhn, B. A., O. Silvennoinen, O. Miura, K. S. Lai, C. Cwik, E. T. Liu, and J. N. Ihle. 1994. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370:153.
31. Nielsen, M., A. Svejgaard, S. Skov, and N. Ødum. 1994. Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Eur. J. Immunol. 24:3082.
32. Ihle, J. N. 1995. Cytokine receptor signalling. Nature 377:591.
33. Paul, W. E., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241.
34. Mulloy, J., A. Cereseto, M. Klotman, T. S. Migone, W. Leonard, and G. Franchini. 1995. HTLV-1 and the IL-2R pathway. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10:214 (Abstr.).
35. Bierer, B., S. Schreiber, and S. Burakoff. 1991. The effect of the immunosuppressant FK506 on alternate pathways of T cell activation. Eur. J. Immunol. 21:439.
36. Maruyama, M., H. Shibuya, H. Harada, M. Hatakeyama, M. Seiki, T. Fujita, J. Inoue, M. Yoshida, and T. Taniguchi. 1987. Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Tl complex triggering. Cell 48:343.
37. + cytotoxic T lymphocytes specific for HTLV-1 pX in patients with HTLV-1 associated neurological disease. Nature 348:245.
38. Elovaara, I., S. Koenig, Y. Brewah, R. M. Woods, T. Lehky, and S. Jacobson. 1993. High human T cell lymphotropic virus type I (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J. Exp. Med. 177:1567.